Koyfin Home > Directory > Health Care > Ironwood Pharmaceuti > EBITDA

Ironwood Pharmaceuti EBITDA Chart (IRWD)

Ironwood Pharmaceuti annual/quarterly EBITDA from 2010 to 2020. EBITDA stands for earnings before interest, taxes, depreciation and amortization. EBITDA is one indicator of a company's financial performance and is used as a proxy for the earning potential of a business, although doing so can have drawbacks. EBITDA strips out the cost of debt capital and its tax effects by adding back interest and taxes to earnings.
  • Ironwood Pharmaceuti EBITDA for the quarter ending June 06, 2020 was $33m a -106.56% decrease of -36m year over year
  • Ironwood Pharmaceuti EBITDA for the last 12 months ending June 06, 2020 was $168m a 33.81% increase of 57m year over year
  • Ironwood Pharmaceuti Annual EBITDA for 2019 was $129m a 100.80% increase of 130m from 2018
  • Ironwood Pharmaceuti Annual EBITDA for 2018 was $-1m a -3,096.62% increase of 32m from 2017
  • Ironwood Pharmaceuti Annual EBITDA for 2017 was $-33m a 7.06% decrease of -2m from 2016
Other Income Statement Metrics:
  • Ironwood Pharmaceuti Net Income for the quarter ending December 12, 2018 was $-15m a -178.47% increase of 28m year over year
  • Ironwood Pharmaceuti Total Revenue for the quarter ending September 09, 2018 was $66m a -43.42% decrease of -29m year over year
View Chart On Koyfin

Quarterly IRWD EBITDA Data

06/2020$33m
03/2020$14m
12/2019$53m
09/2019$69m
06/2019$21m
03/2019$-12m
12/2018$33m
09/2018$-16m
06/2018$-7m
03/2018$-28m

Annual IRWD EBITDA Data

2019$129m
2018$-1m
2017$-33m
2016$-31m
2015$-90m
2014$-153m
2013$-240m
2012$-61m
2011$-56m
2010$-55m